Announcements

Default Banner

DYNALABS PARTNERS HONORED by WEBSTER UNIVERSITY

DYNALABS Honored

Michael Pruitt, CEO & Managing Partner DYNALABS LLC, and V.C. “Jun” Fabella Jr., EVP & Partner  DYNALABS LLC, are being honored as Outstanding Alumnus for the George Herbert Walker School of Business & Technology.  The award recognizes alumni who have achieved outstanding success and recognition in their profession. Both Michael and Jun received their MBAs from the Webster University in 1994. Award Honorees are invited to attend the President’s Commencement dinner on Friday, May 10th…

Read More


DYNALABS ANNOUNCES FORMATION OF THE“DYNALABS NEW VENTURES INITIATIVE”

For Immediate Release, ST. LOUIS, MO, April 22, 2019 – DYNALABS is excited to announce the formation of the DYNALABS New Ventures Initiative (DNVI). This new initiative will be led by Jun Fabella. In his new role as Executive Vice President of DNVI, Jun will be responsible for identifying and executing on the viability and commercial value of unique business opportunities and innovations. Over our exciting fifteen-year history, DYNALABS has often been presented with unique…

Read More


DYNALABS welcome consulting group AMICUS cGMP

DYNALABS announces today that its consulting division has separated into the independent consulting group, AMICUS cGMP Consultants.  New CEO & Principal Consultant, Kristopher Le, is based in Lexington, SC, and he assures everyone that AMICUS Consultants will continue to work with DYNALABS, LLC. AMICUS’ mission is to offer consulting services to pharmaceutical compounders and manufacturers, thus improving the overall safety and quality of their products.  While AMICUS and DYNALABS will cooperate strategically, the separation into different business…

Read More



DYNALABS is pleased to announce Nichole DiLoretta as our Vice President of Operations.

Nichole DiLoretta supports our company’s quality driven and focused direction. DYNALABS is focused on sustainability with a quality focused approach in our operations. We not only want to meet our current client and regulatory needs in today’s economy, but we also want to be proactive to position DYNALABS ahead of the curve to anticipate the future needs of our clients and the industry.

Read More


DYNALABS Named One of the Nation’s Fastest-Growing Inner City Businesses

The Initiative for a Competitive Inner City (ICIC) announced that St. Louis’s DYNALABS has made the 2018 Inner City 100 list of the fastest-growing inner city businesses in America, based on revenue growth. This is the second time that DYNALABS has earned this award. ICIC is a 25-year-old national nonprofit founded by Harvard Business School professor Michael E. Porter. The organization promotes economic prosperity in America’s inner cities through private sector investment that leads to jobs, income and wealth creation for local residents.

Read More


“Maximizing the full potential of others”

DYNALABS’ own Nichole DiLoretta was nominated to be one of the Wonder Women for St. Louis Small Business monthly. We very proud of her and her devotion to us here at DYNALABS but to the people she helps outside the work place. Nice Work Nicole!

Read More


Announcing a new National Accounts Manager, Christine Versichele.

In this role, Christine’s focus will be working directly with strategic multi-national and global accounts within the pharmaceutical compounding industry. This focus is consistent with DYNALABS’ business model for sustainable accelerated growth. We believe Christine’s vast industry knowledge and experience will serve her well in identifying new opportunities and developing cost-effective custom solutions. As National Account Manager, Christine will further promote DYNALABS’ guiding principles – Patient Safety, Affordable Healthcare, and Business Success – within the…

Read More



Using USP to determine Microbial Enumeration

DYNALABS provides USP <61> as the pinnacle test to determine Microbial Enumeration (aka bioburden) in non-sterile samples. This microbial analysis acts as a quasi-sterility test with an expected CFU count for monitoring the microbiological profile of a product’s ingredients and of finished products.

Read More